Contact Us Product Guide Drug Information Site Map


Generic Business Strategies > Generic Corporate Development

To support its business strategies, the Company continually evaluates acquisition opportunities to strengthen its product portfolio and help grow its generic business. Barr regularly evaluates opportunities such as strategic product acquisitions, new technology arrangements including new technology platforms, and corporate mergers and acquisitions.

Generic Business Overview
Generic Business Strategies
•Unique Generic Products
•Patent Challenges
•New Technology Platforms
•Corporate Development
Key Generic Products
Generic Product Pipeline
Generic Sales Process
FAQ About Generics
FDA Approval Process
History of Generic Industry
Industry Links
Clinical Trials
Barr Pharmaceuticals, Inc. Terms of Use Legal Notice Privacy Policy